These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 23034699)

  • 1. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.
    Stevens JW; Simpson E; Harnan S; Squires H; Meng Y; Thomas S; Michaels J; Stansby G
    Br J Surg; 2012 Dec; 99(12):1630-8. PubMed ID: 23034699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease.
    Squires H; Simpson E; Meng Y; Harnan S; Stevens J; Wong R; Thomas S; Michaels J; Stansby G
    Health Technol Assess; 2011 Dec; 15(40):1-210. PubMed ID: 22142554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease.
    Meng Y; Squires H; Stevens JW; Simpson E; Harnan S; Thomas S; Michaels J; Stansby G; O'Donnell ME
    Angiology; 2014 Mar; 65(3):190-7. PubMed ID: 23378195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).
    Roset PN
    Br J Surg; 2013 Dec; 100(13):1838. PubMed ID: 24227374
    [No Abstract]   [Full Text] [Related]  

  • 5. Authors' reply: systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).
    Stevens JW; Simpson E; Harnan S; Squires H; Meng Y; Thomas S; Michaels J; Stansby G
    Br J Surg; 2013 Dec; 100(13):1838-9. PubMed ID: 24227373
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Guest JF; Davie AM; Clegg JP
    Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cilostazol for intermittent claudication.
    Brown T; Forster RB; Cleanthis M; Mikhailidis DP; Stansby G; Stewart M
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD003748. PubMed ID: 34192807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol for intermittent claudication.
    Bedenis R; Stewart M; Cleanthis M; Robless P; Mikhailidis DP; Stansby G
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD003748. PubMed ID: 25358850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentoxifylline for intermittent claudication.
    Broderick C; Forster R; Abdel-Hadi M; Salhiyyah K
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD005262. PubMed ID: 33063850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The limits of evidence in drug approval and availability: a case study of cilostazol and naftidrofuryl for the treatment of intermittent claudication.
    Hong H; Mackey WC
    Clin Ther; 2014 Aug; 36(8):1290-301. PubMed ID: 25012728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naftidrofuryl for intermittent claudication.
    de Backer TL; Vander Stichele R; Lehert P; Van Bortel L
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD001368. PubMed ID: 23235580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentoxifylline for intermittent claudication.
    Salhiyyah K; Forster R; Senanayake E; Abdel-Hadi M; Booth A; Michaels JA
    Cochrane Database Syst Rev; 2015 Sep; 9(9):CD005262. PubMed ID: 26417854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endovascular revascularisation versus conservative management for intermittent claudication.
    Fakhry F; Fokkenrood HJ; Spronk S; Teijink JA; Rouwet EV; Hunink MGM
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010512. PubMed ID: 29518253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostanoids for intermittent claudication.
    Robertson L; Andras A
    Cochrane Database Syst Rev; 2013 Apr; (4):CD000986. PubMed ID: 23633305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naftidrofuryl for intermittent claudication.
    De Backer TL; Vander Stichele R; Lehert P; Van Bortel L
    Cochrane Database Syst Rev; 2008 Apr; (2):CD001368. PubMed ID: 18425872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials.
    Regensteiner JG; Ware JE; McCarthy WJ; Zhang P; Forbes WP; Heckman J; Hiatt WR
    J Am Geriatr Soc; 2002 Dec; 50(12):1939-46. PubMed ID: 12473004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data.
    De Backer T; Vander Stichele R; Lehert P; Van Bortel L
    BMJ; 2009 Mar; 338():b603. PubMed ID: 19276131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentoxifylline for intermittent claudication.
    Salhiyyah K; Senanayake E; Abdel-Hadi M; Booth A; Michaels JA
    Cochrane Database Syst Rev; 2012 Jan; 1():CD005262. PubMed ID: 22258961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Naftidrofuryl in arterial obstructive disease: A systematic revue of the literature].
    Bourrion B; Hazard A; Baltazard H; Sebbag P; Fournier L; François M
    Rev Med Interne; 2020 Feb; 41(2):89-97. PubMed ID: 31669163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review the efficacy and safety of cilostazol, pentoxifylline, beraprost in the treatment of intermittent claudication: A network meta-analysis.
    Liang X; Wang Y; Zhao C; Cao Y
    PLoS One; 2022; 17(11):e0275392. PubMed ID: 36318524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.